GRCE
Grace Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.20
+0.14 ▲ +3.45%
🌙 3월 13일 7:09 PM ET (한국 3/14 08:09)
$4.24
+0.04 ▲ +1.07%
| Index | - | P/E | - | EPS (ttm) | -0.36 | Insider Own | 27.06% | Shs Outstand | 0.02B | Perf Week | 8.81% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 23.21% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 16.99% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.24 | Inst Own | 27.97% | Short Float | 3.46% | Perf Quarter | 23.89% |
| Income | -0.01B | P/S | - | EPS this Y | -6.33% | Inst Trans | 9.41% | Short Ratio | 2.33 | Perf Half Y | 30.43% |
| Sales | 0.00B | P/B | 1 | EPS next 5Y | - | ROA | -9.22% | Short Interest | 0.39M | Perf YTD | 21.39% |
| Book/sh | 4.19 | P/C | 3.48 | EPS past 3/5Y | 20.89% 44.08% | ROE | -10.22% | 52W High | -9.68% ($4.65) | Perf Year | 83.41% |
| Cash/sh | 1.21 | P/FCF | - | Sales past 3/5Y | - | ROIC | -9.21% | 52W Low | 140% ($1.75) | Perf 3Y | 54.19% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.83% | Gross Margin | - | Volatility(W/M) | 8.65% 6.8% | Perf 5Y | -87.91% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.27 | Perf 10Y | -94.88% |
| Dividend Ex-Date | - | Quick Ratio | 14.96 | EPS Q/Q | 62.14% | Profit Margin | - | RSI (14) | 62.87 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.96 | Sales Q/Q | - | SMA20 | 5.69% ($3.97) | Beta | 0.76 | Target Price | $11.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 11.18% ($3.78) | Rel Volume | 2.22 | Prev Close | $4.06 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | 50% - | SMA200 | 27.93% ($3.28) | Avg Volume(3M) | 0.17M | Price | $4.2 |
| IPO | 2011/5/6 | Option/Short | Yes/Yes | Trades | 1053 | Volume | 372,714 | Change | 3.45% |
뉴스 로딩 중...